Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: TDS, AVO

Xi stresses common development, win-win cooperation


BEIJING, Jan. 17, 2022  /PRNewswire/ -- A report from chinadaily.com.cn: 

President Xi Jinping delivered a speech at a virtual event of the World Economic Forum on Monday amid anticipation of China's contribution to global economic recovery. This was his third time speaking at the forum as a head of state.

A highlight from President Xi Jinping's speech at a virtual event of the World Economic Forum on Monday, Jan 17, 2022. [Graphic by chinadaily.com.cn]

Here are some highlights:

On China's economy

- We have every confidence in the future of China's economy

- China's development gains will benefit all its people in a more substantial and equitable way

- China should never grow the economy at the cost of resource depletion and environmental degradation, nor should the country sacrifice growth to protect the environment

On global recovery

- World should follow logic of historical progress, ride tide of times

- No 'counter-currents' can stop trend of economic globalization

- Different countries and civilizations may prosper together on the basis of respect for each other, and seek common ground and win-win outcomes by setting aside differences

A highlight from President Xi Jinping's speech at a virtual event of the World Economic Forum on Monday, Jan 17, 2022. [Graphic by chinadaily.com.cn]

On COVID-19

- Countries need to strengthen international cooperation against COVID-19, carry out active cooperation on research and development of medicines

- Of particular importance is to fully leverage vaccines as a powerful weapon, ensure their equitable distribution

- China will provide another 1 billion COVID-19 vaccine doses to African countries, and donate 150 million doses to ASEAN countries

On Winter Games

Photo - https://mma.prnewswire.com/media/1728251/image_1.jpg
Photo - https://mma.prnewswire.com/media/1728250/image_2.jpg


These press releases may also interest you

at 04:00
Bioforum, the Data Masters, a leading contract research organization (CRO) focused on the delivery of biometric services and solutions to the global clinical trials industry, today announced the launch of SUBMIT24 in its beta version during Q3 2024,...

at 04:00
TVM Capital Healthcare, a specialist healthcare private equity firm headquartered in Dubai and...

at 03:26
Calliditas Therapeutics AB , ("Calliditas") today announced that the global open-label extension (OLE) study to the Phase 3 NefIgArd study showed a treatment response consistent with the NefIgArd study across endpoints of urine protein to creatinine...

at 03:00
Flindr...

at 03:00
CSL Vifor and Travere Therapeutics, Inc., today announced that the European Commission has granted conditional marketing authorization (CMA) for FILSPARI (sparsentan) for the...

at 03:00
Tetra Pharm Technologies and Glysious are pleased to announce a strategic collaboration aimed at developing a ground-breaking transdermal drug delivery system complementing several of Tetra Pharm Technologies' pipeline candidates. The...



News published on and distributed by: